Acetyl Fentanyl: Dangerous, Poorly-Named Street Drug
Aug30

Acetyl Fentanyl: Dangerous, Poorly-Named Street Drug

The U.S. Centers for Disease Control and Prevention has released a summary on a cluster of 14 deaths in Rhode Island earlier this year attributed to “acetyl fentanyl,” an analog of the potent, short-lived opioid used in pain management and outpatient anesthesia. The report, “Notes from the Field: Acetyl Fentanyl Overdose Fatalities — Rhode Island, March–May 2013,” appears in the August 30, 2013 issue of...

Read More
Okay, Who’s Huffing Vicks VapoRub?
Nov14

Okay, Who’s Huffing Vicks VapoRub?

One of the fun things about having a blog is the traffic analytics feature on the dashboard of WordPress (although I really miss the features of SiteMeter that don’t run on WordPress because it doesn’t accept JavaScript. But I digress.) Besides the addictive nature of looking at one’s traffic numbers, I always find it interesting to look at the search terms that bring people to our humble little corner of CENtral...

Read More
Smiles: 2C-I or not 2C-I?
Oct01

Smiles: 2C-I or not 2C-I?

Designer drugs in the news This is tiring enough for a science writer. I cannot imagine being in law enforcement. The pace at which psychoactive designer drugs are appearing on the street is about as challenging for me as keeping up with dietary supplement companies that adulterate their products with actual prescription drugs (an area I’ve been covering since 2007 but a practice that goes back decades.) This week’s...

Read More
RTI scientists solving forensic, designer drug mysteries
Sep09

RTI scientists solving forensic, designer drug mysteries

Catching up on my reading this Sunday morning, I’m beaming with pride on the collective accomplishments and coverage of some old friends and colleagues. Kerstin Nordstrom, a AAAS Mass Media Fellow with the Raleigh News & Observer, had a nice story on 3 September about the work of Dr. Peter Stout at RTI International. You old-timers will know this non-profit entity as Research Triangle Institute, home to the discoveries of...

Read More
DEA jams synthetic marijuana and “bath salts” industry
Jul28

DEA jams synthetic marijuana and “bath salts” industry

With all the discord in Washington these days, it’s rare to see several US governmental organizations working together to address a significant public health problem. This week, the US Drug Enforcement Agency (DEA) mobilized Operation Log Jam, an unusual and highly-coordinated action with six other federal agencies aimed to shut down the synthetic designer drug industry in 109 US cities. The products targeted were of two broad...

Read More

NIDA seeks SBIR/STTR apps on Spice, bath salts

C&EN senior business editor Melody Bomgardner dropped me a note yesterday about a new request for applications from NIH’s National Institute on Drug Abuse (NIDA) for small business grants. Read the text below but here’s what I find interesting as a pharmacologist who plays well with chemists: the call for applications is not for analytical methods for designer drugs. Rather the announcement solicits novel methods for...

Read More